000			02081 a2200601 4500
005			20250515200734.0
264		0	_c20100308
008			201003s 0 0 eng d
022			_a1477-0970
024	7		_a10.1177/1352458509350309 _2doi
040			_aNLM _beng _cNLM
100	1		_aPatti, F
245	0	0	_aEffects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. _h[electronic resource]
260			_bMultiple sclerosis (Houndmills, Basingstoke, England) _cJan 2010
300			_a68-77 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aDisability Evaluation
650	0	4	_aDisease Progression
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEndpoint Determination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aInjections, Subcutaneous
650	0	4	_aInterferon beta-1a
650	0	4	_aInterferon-beta _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xcomplications
650	0	4	_aNeuropsychological Tests
650	0	4	_aProspective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aYoung Adult
700	1		_aAmato, M P
700	1		_aBastianello, S
700	1		_aCaniatti, L
700	1		_aDi Monte, E
700	1		_aFerrazza, P
700	1		_aGoretti, B
700	1		_aGallo, P
700	1		_aMorra, V Brescia
700	1		_aLo Fermo, S
700	1		_aPicconi, O
700	1		_aTola, M R
700	1		_aTrojano, M
773	0		_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 16 _gno. 1 _gp. 68-77
856	4	0	_uhttps://doi.org/10.1177/1352458509350309 _zAvailable from publisher's website
999			_c19378347 _d19378347